Type 1 Diabetes

By Dave Muoio March 20, 2018
Data from a team of Dutch researchers presented this weekend at the Endocrinology Society’s annual meeting in Chicago demonstrated how vital monitoring wearables could identify Type 1 diabetes patients’ hypoglycemic events by measuring heart rate. The pilot study outfitted 27 adult patients with VitalConnect’s HealthPatch MD, a continuous health monitor that the company has since replaced with...
By Dave Muoio February 26, 2018
The FDA has expanded its indication for Medtronic’s Guardian Sensor 3, allowing patients to wear the sensor on their upper arm. The sensor is part of Medtronic’s MiniMed 670G system, and is currently the only continuous glucose monitor approved by the FDA to control automated insulin delivery via a hybrid closed loop system. Along with the added convenience of the new sensor site, the company...
By Dave Muoio February 5, 2018
The Juvenile Diabetes Research Foundation (JDRF) and Massachusetts-based Cam Med, a company specializing in microfluidic-based drug delivery technologies, announced a partnership today focused on development of a thin, flexible, patch-based insulin pump for artificial pancreas systems. "JDRF is excited to partner with Cam Med on improving insulin delivery hardware,” Jaime Giraldo, program...
By Laura Lovett January 2, 2018
Using an artificial pancreas (closed-loop control system) could make it easier for adolescents with Type 1 diabetes to participate in intensive outdoor physical activities, according to a study published in Diabetes Care.  The study, which had participants ski or snowboard for five days, found that subjects who used an artificial pancreas maintained a healthy blood sugar level more of the time...
By Dave Muoio December 18, 2017
Milpitas, California-based diabetes management device maker Bigfoot Biomedical has raised $37 million in Series B funding in a round co-led by funds from Janus Henderson Investors and Quadrant Capital Advisors. Additional participants included Cormorant Asset Management, Senvest Capital Inc., Senvest Management LLC, Visionnaire Ventures, JDRF T1D Fund, and T1D Exchange. Bigfoot previously...
By Jeff Lagasse August 21, 2017
IBM and JDRF, a global organization funding Type 1 diabetes research, are joining forces. The collaboration will develop machine learning methods and use them to analyze years of Type 1 research data to pinpoint the factors that can contribute to the onset of the condition in children.   Type 1 diabetes  -- T1D for short -- affects about 1.25 million Americans, and to date does not have a cure....
By Jonah Comstock May 12, 2017
A new partnership in the diabetes space could bring the promise of an artificial pancreas closer to reality. Senseonics, a Germantown, Maryland company working on a pill-sized, implantable continuous glucose monitor that can last 90 days without needing replacement, will work with digital, personalized medicine company TypeZero Technologies on a project to integrate readings from Senseonics...
By Jonah Comstock October 11, 2016
Patients Pending, a London-based health startup founded by one of the co-creators of Skype and his brother, has announced that it will follow up its Timesulin insulin pen cap with a Bluetooth-connected insulin pen cap, which the company hopes will help create smart dosing systems for patients with Type 1 diabetes who don’t use an insulin pump.  “Our hypothesis has been, so much of the investment...
By Jonah Comstock October 6, 2016
Boston-based nonprofit T1D Exchange has announced its intentions to make a multi-million dollar investment in automated insulin delivery technologies, the smart algorithms that serve as the bridge between CGMs and insulin pumps in the quest to create an artificial pancreas. “Type 1 diabetes is a disease that, since the invention of artificial insulin back in 1921, still plagues us because...
By Jonah Comstock November 11, 2015
When Kenneth Stack's son was diagnosed with Type 1 diabetes just before his fifth birthday, the doctor told Stack he was just a few years too early for a major medical breakthrough. "I remember, trying to make sense of all of this, the doctor saying 'In three years, we’ll have perfected the artificial pancreas and you won’t have to worry about this'," Stack recalled at a panel discussion at the...

Editor's Pick